Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128(b)(4) — License Revocation/Suspension · Date: 10/20/2024 · State: FL
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
697
Total Claims
$50K
Drug Cost
54
Beneficiaries
$932
Cost/Patient
Risk Score Breakdown 46/100
Score components are additive. Read full methodology
Peer Comparison vs. 22,639 Obstetrics & Gynecology providers
+1758%
Opioid rate vs peers
23.8% vs 1.3% avg
+148%
Cost per patient vs peers
$932 vs $376 avg
-36%
Brand preference vs peers
7.7% vs 12.1% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider appears on the federal OIG exclusion list, meaning they have been formally barred from participating in federal healthcare programs due to fraud, patient abuse, licensing issues, or other misconduct. The fact that they still appear in active prescribing data is a significant concern.
Opioid prescribing rate is 1,758% above the average for Obstetrics & Gynecology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
23.8%
Opioid Rate
166
Opioid Claims
$6,581
Opioid Cost
—
Long-Acting Rate
This provider's opioid prescribing rate of 23.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 54 claims · $12K
Generic: 643 claims · $38K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 57 | $6,169 |
| Oxycodone Hcl | 126 | $5,332 |
| Buprenorphine Hcl/Naloxone Hcl | 11 | $4,481 |
| Albuterol Sulfate | 23 | $774 |
| Oxycodone Hcl/Acetaminophen | 17 | $645 |
| Ibuprofen | 49 | $575 |
| Hydromorphone Hcl | 18 | $490 |
| Ondansetron | 12 | $423 |
| Butalb/Acetaminophen/Caffeine | 11 | $273 |
| Lisinopril | 23 | $249 |
| Clonazepam | 36 | $241 |
| Trazodone Hcl | 30 | $207 |
| Estradiol | 11 | $133 |
| Promethazine Hcl | 12 | $119 |
| Atorvastatin Calcium | 13 | $96 |
Prescribing Profile
17
Unique Drugs
46.0
Anomaly Score
Patient Profile
63
Avg Age
59%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data